President Donald Trump signed an executive order on April 18, 2026 [1], to accelerate the federal review of the psychedelic drug ibogaine.
The move signals a shift in conservative politics toward the acceptance of psychedelic therapies. This alignment suggests that bio-hacking and alternative medicine are becoming viable points of interest for the GOP.
Conservative activist Bryan Hubbard led the effort to persuade the president and the Republican party to embrace the substance. Hubbard worked with former Texas Governor Rick Perry and podcast host Joe Rogan to champion the drug's potential [1].
Proponents argue that ibogaine shows promise for treating addiction, and other mental-health conditions [2]. The drug has long been controversial due to its potency and the nature of its effects, but it is now receiving high-level political backing.
The executive order directs the Department of Health and Human Services and other federal agencies to speed up the regulatory process [1]. This administrative push aims to determine if the drug can be safely integrated into medical practice for those struggling with substance abuse.
The shift reflects a broader trend where right-wing figures are increasingly interested in alternative therapies to address public health crises. By framing the use of psychedelics as a tool for recovery and personal optimization, these activists are attempting to decouple the substances from their traditional counter-culture associations [2].
“President Donald Trump signed an executive order on April 18, 2026, to accelerate the federal review of the psychedelic drug ibogaine.”
The federal acceleration of ibogaine's review represents a strategic pivot in the 'war on drugs' framework. By adopting psychedelic research, the current administration is blending conservative interests in individual health optimization with a pragmatic approach to the addiction epidemic, potentially shifting the regulatory landscape for other scheduled substances.
